Lanean...

Re-purposing cancer therapeutics for breast cancer immunotherapy

After decades of work to develop immune-based therapies for cancer, the first drugs designed specifically to engage the host anti-tumor immune response for therapeutic benefit were recently approved for clinical use. Sipuleucel-T, a vaccine for advanced prostate cancer, and ipilimumab, a monoclonal...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile nagusia: Emens, Leisha A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer-Verlag 2012
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3582212/
https://ncbi.nlm.nih.gov/pubmed/22454154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-012-1247-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!